{
    "clinical_study": {
        "@rank": "85670", 
        "arm_group": [
            {
                "arm_group_label": "Scaling and root planing plus Azithromycin", 
                "arm_group_type": "Experimental", 
                "description": "Single session of scaling and root planning. Azithromycin tablets 500mg, 1 tablet every 24 hours for 5 days"
            }, 
            {
                "arm_group_label": "Scaling and root planing plus placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Single session of scaling and root planning placebo tablets 500mg, 1 tablet every 24 hours for 3 days"
            }, 
            {
                "arm_group_label": "baselline screening only", 
                "arm_group_type": "No Intervention", 
                "description": "Dental prophylaxis is offered"
            }
        ], 
        "brief_summary": {
            "textblock": "Human periodontitis is a group of highly prevalent oral inflammatory diseases and infections\n      with relatively easy treatment and preventive features. The present study is aimed to\n      determine if treating human individuals with chronic periodontitis, along with the use of\n      antibiotics, reduces cardiovascular risk  marker (HsPCR) and also intends to identify if\n      severity of periodontitis could be associated with a raise of systemic inflammatory\n      biomarkers on baseline."
        }, 
        "brief_title": "STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER HIGH SENSITIVE C-REACTIVE PROTEIN. RANDOMIZED CONTROLLED CLINICAL TRIAL.", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Periodontitis", 
        "condition_browse": {
            "mesh_term": [
                "Periodontitis", 
                "Chronic Periodontitis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  must be of legal age (\u2265 18 years old)\n\n          -  voluntary participation and signed information consent\n\n          -  confirmed systemically healthy individual\n\n          -  at least 15 teeth present in mouth\n\n        Exclusion Criteria\n\n          -  pregnant women\n\n          -  smokers\n\n          -  antibiotic consumption 6 months before inclusion\n\n          -  HIV positive or AIDS\n\n          -  Allergic reactions to macrolides and specifically to azithromycin\n\n          -  Periodontal treatment 6 months before inclusion"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "75", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01906450", 
            "org_study_id": "CL1688"
        }, 
        "intervention": [
            {
                "arm_group_label": "Scaling and root planing plus Azithromycin", 
                "description": "Single session of scaling and root planning using ultrasonic device. Azithromycin tablets 500mg, 1 tablet every 24 hours for 5 days", 
                "intervention_name": "Scaling and root planing plus Azithromycin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Scaling and root planing plus placebo", 
                "description": "Single session of scaling and root planning placebo tablets 500mg, 1 tablet every 24 hours for 3 days", 
                "intervention_name": "Scaling and root planing plus placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Bacterial Agents", 
                "Azithromycin", 
                "Antibiotics, Antitubercular"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 19, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Cali", 
                    "country": "Colombia"
                }, 
                "name": "Universidad Del Valle"
            }
        }, 
        "location_countries": {
            "country": "Colombia"
        }, 
        "number_of_arms": "3", 
        "official_title": "STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER HIGH SENSITIVE C-REACTIVE PROTEIN. RANDOMIZED CONTROLLED CLINICAL TRIAL.", 
        "other_outcome": {
            "description": "evaluate the effect of periodontal therapy alone or with azithromycin on periodontal parameters (probing deep, bleeding on probing, clinical atachment level) in patients with chronic periodontitis.", 
            "measure": "STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER PERIODONTAL PARAMETERS", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Colombia: Institutionl Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "High sensitive C reactive protein - hs-PCR levels evaluate the effect of periodontal therapy alone or with azithromycin on levels of high sensitivity C-reactive protein (hs CRP) in patients with chronic periodontitis", 
            "measure": "EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER HIGH SENSITIVE C-REACTIVE PROTEIN.", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01906450"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Universidad del Valle, Colombia", 
            "investigator_full_name": "Jorge Enrique Soto", 
            "investigator_title": "periodontist Cert. DDS", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "evaluate the effect of periodontal therapy alone or with azithromycin on levels of profile lipidic (Total cholesterol, triglycerides, HDL, LDL) in patients with chronic periodontitis", 
                "measure": "STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER LIPIDIC PROFILE", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "evaluate the effect of periodontal therapy alone or with azithromycin on levels of glycemia in patients with chronic periodontitis", 
                "measure": "STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER GLYCEMIA LEVELS", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "evaluate the effect of periodontal therapy alone or with azithromycin on blood biochemistry (arterial index, hemogram) in patients with chronic periodontitis.", 
                "measure": "STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER BLOOD BIOCHEMISTRY", 
                "safety_issue": "No", 
                "time_frame": "3 MONTHS"
            }
        ], 
        "source": "Universidad del Valle, Colombia", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Universidad del Valle, Colombia", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}